Karen Sterling, PhD, CFA
Interim Executive Director, NYSSA
Karen Sterling, PhD, CFA, is the managing director of healthcare investment banking at Avalon Group, a Manhattan boutique, where she offers fundraising and strategic advisory services to companies in the biotechnology, pharmaceutical, medical devices, healthcare services, and healthcare IT sectors. Previously, she was vice president and senior analyst at Fridson Investment Advisors, an investment management firm specializing in corporate credit opportunities, and prior to that quantitative and fundamental analyst at Martin Fridson’s FridsonVision. Until 2009, she also published equity research reports and financial analysis of life sciences companies through Karen Sterling Bio-Pharma Insight. An active NYSSA member since 2003, Sterling was a founding member NYSSA’s Toastmasters group, and a founding member of the editorial board of The Investment Professional, to which she contributed a peer-reviewed research article. In addition to being awarded the CFA designation in 2006, Sterling earned two master’s degrees and a PhD in biochemistry and molecular biophysics from Columbia University. In 2005, while deployed to Antarctica as a research scuba diver on an NSF-funded project, she became the only financial analyst in history to update her equity research coverage via satellite from a remote field camp on the Antarctic continent.